Elevated levels in adults may sometimes indicate cancers of stomach, colon, lung, and breast. If AFP levels do not significantly decrease after cancer treatment, this may indicate presence of some of the tumor tissue. If the levels begin to increase after cancer treatment, then it is likely that the cancer may be recurring.

Why is Alpha Feto Protein, Tumour Marker done?

• The alpha-fetoprotein tumor marker is done:
• In case cancers of the liver, testicles, or ovaries are suspected
• At intervals during and after treatment for any of these cancers
• In the case of cancer-predisposing diseases such as chronic hepatitis or cirrhosis
• To monitor the patients for cancer recurrence

What does Alpha Feto Protein, Tumour Marker Measure?
The alpha-fetoprotein (AFP), tumour marker test measures the levels of AFP in the blood. AFP is a protein which is produced mainly by the liver in a fetus (developing baby) and the portion of a developing embryo. The levels of AFP are elevated at the time of the baby’s birth and then the levels decline.

In case of liver damage and certain cancers, the AFP concentrations are raised.

The production of AFP occurs at the time of regeneration of liver cells. In case of chronic liver diseases, such as cirrhosis and hepatitis, AFP may be raised chronically. Certain tumors produce very high concentrations of AFP. Thus, AFP test is a useful tumor marker test.

Increased levels of AFP can be seen in hepatocellular carcinoma (type of liver cancer), hepatoblastoma (liver cancer occurring in infants), cancer of the testicles or ovaries.